Navigation Links
Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
Date:4/5/2011

on MDS and TELINTRA

The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis (blood cell production) involving one or more cell lineages (red blood cells, white blood cells or platelets) and a variable risk of transformation to acute myeloid leukemia (AML).  MDS becomes more common with age.  It is estimated that MDS affects approximately 300,000 people worldwide.  According to the American Cancer Society, 10,000–20,000 new cases of MDS are diagnosed each year in the United States, with survival rates ranging from six months to six years.  MDS patients often require blood transfusions to manage their disease.

There remains a critical need for effective, well tolerated therapies for MDS.  Telintra has a novel mechanism of action that inhibits an enzyme called glutathione S-transferase P1-1, which leads to activation of Jun kinase, a key regulator of cellular growth and differentiation of blood precursor cells.  Telintra has been shown to stimulate normal multilineage differentiation of blood stem cell precursors and induce cancer cell death, or apoptosis, in human leukemia cell lines.  Additional information about Telintra is available at www.telik.com.

About Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small m
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
2. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
3. Telik Announces Presentation and Webcast at 13th Annual BIO CEO & Investor Conference
4. Telik Announces Presentation at American Society of Hematology Annual Meeting
5. Telik Announces Third Quarter 2010 Financial Results
6. Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects
7. Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
8. Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl)
9. Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance
10. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
11. Telik Announces Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Chiron Corporation notified the CDC that none of its influenza ... States for the current influenza season. In the wake of ... vaccine supply, medical officials and the general public have grown ... of a looming epidemic. , ,It remains to be seen ...
... PSA test has been widely used as the gold standard ... reversals in recent diagnostic science, a recent study at Stanford ... now put the utility of the procedure in grave doubt. ... States, said Thomas Stamey, MD, professor of urology and lead ...
Cached Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3PSA TestingHow Much is Too Much? 2PSA TestingHow Much is Too Much? 3
(Date:4/18/2014)... 21, 2014) -- A group of scientists from ... the Sanders-Brown Center on Aging has found interesting ... neuropsychological function in Parkinson,s disease (PD). , ... the study, which assessed cognitive function in depressed ... dopamine replacement therapy commonly used to treat motor ...
(Date:4/18/2014)... School of Medicine researchers have been awarded two-year grants ... Nordisk announced this month. Of the 110 initial submissions ... Science Forum Program, only four projects were funded, three ... are Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; ... a professor of oncology, will use his $500,000 proof ...
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2
... Serbia has been reported, much to the concern of the ... been suspected of carrying the deadly H5N1 virus. ... eastern Serbian region have been found to show symptoms of ... to testing laboratory in Britain to confirm the suspicion, said ...
... HIV/AIDS workshop held on Tuesday speakers have raised an ... to prevent it from spreading in the country.// ... a disease” was organised by the provincial AIDS Control ... ,One of the speakers NWFP Health Minister Inayatullah Khan ...
... The stage is set for the final hearing of India's ... hospital charged with negligence in a woman's death eight years ... realise my case can again be postponed by the machinations ... Wednesday, a day ahead of the final hearing at the ...
... About 117,619 frozen embryos are stored in Britain. They are living ... waiting for their lives to begin again. // , ... 1997, but was born in April 2000. Her gestation period lasted ... Lois had been an eight-celled embryo and spent about 30 months ...
... launched the world's largest medical experiment at Altrincham, Cheshire. // ... to the first set of participants. The main aim of ... of cancer, heart disease, diabetes, dementia, joint disease and many ... reveal the truth of why some people would die before ...
... by a team of researchers from Warwick Medical School found ... neglect. // ,The study included 120,000 children born ... who had a low birth weight and were born premature ... ,Premature babies include those that were born before 34 ...
Cached Medicine News:Health News:Stage Set For Final Hearing On India’s Biggest Ever Medical Compensation Clai 2Health News:Frozen embryos stored in Britain 2Health News:UK Biobank Set Up To Understand the Links between Genes, Lifestyle Environment and Illness 2
... from Richmond Products includes the four demonstration plates, ... series for a total of 24 plates. Each ... easy and clean page selection. The test also ... a laminated copy of the score sheet. The ...
Ishihara 14 plate color vision testing set. Suitable for screening purposes....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
... BD Edgeahead Stiletto / MVR knife. 1.1 ... insertion of 1.1 mm (19G) Cannula (5/bx, 1 ... knives are consistently sharp and precise. Sure grip ... edge. Tapered tip creates a fluid tight incision ...
Medicine Products: